<DOC>
	<DOCNO>NCT00776009</DOCNO>
	<brief_summary>This study evaluate efficacy safety Dex-Methylphenidate Extended Release 30 mg compare 20 mg pediatric patient age 6-12 Attention-Deficit Hyperactivity Disorder ( ADHD ) 12-hour laboratory classroom setting .</brief_summary>
	<brief_title>Efficacy Safety Dex-Methylphenidate Extended Release 30 mg Versus 20 mg Children ( 6-12 Years ) With Attention-Deficit/Hyperactivity Disorder ( ADHD ) Laboratory Classroom Setting .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>Male female subject age 612 year , inclusive . Subjects meet DSMIV criterion primary diagnosis ADHDCombined type , predominantly hyperactiveimpulsive subtype , establish KSADSPL ( Kiddie Schedule Affective Disorders SchizophreniaPresent Lifetime Version ) . If DSMIVdefined ADHD diagnosis difficult establish due possible comorbidity , subject enrol study . Subjects stabilize total daily dose near equivalent 4060 mg methylphenidate 2030 mg dmethylphenidate least two week prior Screening visit . Subject subject 's guardian unable understand follow instruction necessary participate study . Diagnosed history tic disorder Tourette 's syndrome . History seizure disorder . The presence know medical condition would preclude use methylphenidate . A history ( within past year ) presence clinically significant cardiovascular , cerebrovascular , renal , hepatic , gastrointestinal , pulmonary , immunological , hematological , endocrine , neurological disease . ALT ( Alanine Amino Transferase ) , AST ( Aspartate Amino Transferase ) , GGT ( Gamma glutamyl transferase ) serum creatinine great 2X ULN ( Upper Limit Normal ) Screening . A history psychiatric illness substance use disorder ( e.g. , schizophrenia , bipolar disorder , autism , abuse dependence , depression , severe Conduct Disorder severe Oppositional defiant disorder ) Subjects participated investigational trial within past 4 week ( 28 day ) Subjects currently take antidepressant psychotropic medication . Subjects initiate psychotherapy three month prior randomization . Subjects positive urine drug screen . Subjects history poor response intolerance methylphenidate dmethylphenidate . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>ADHD , child , subject , laboratory classroom</keyword>
</DOC>